Newswire

[ September 10, 2025 ] Advent Technologies (NASDAQ: ADN) Announces Major Milestone in its Strategic Collaboration with Airbus Newsmakers
[ September 10, 2025 ] Hoth Therapeutics (NASDAQ: HOTH) Secures Key European Regulatory Milestone with EMA Submission for Phase II Trial of HT-001 in Cancer Patients Suffering from EGFRi-Induced Skin Toxicities Newsmakers
[ September 10, 2025 ] Worksport (NASDAQ: WKSP) Posts Fourth Consecutive Monthly Sales Record in July 2025; Gross Margin Reaches 31% Target One Quarter Early Newsmakers
[ September 4, 2025 ] Worksport (NASDAQ: WKSP) Posts Q2 2025 Results: Gross Profit Increases 173%, Revenue Jumps 83%, Margin Expands 870 bps, Operating Loss Improves 15% [QoQ]. Newsmakers
[ September 4, 2025 ] Hoth Therapeutics’ (NASDAQ: HOTH) Cancer Therapeutic HT-KIT Surpasses Preclinical Milestones With Potent Anti-Tumor Activity and GLP-Validated Bioanalytical Results, Exceeding Regulatory Standards Newsmakers
[ August 28, 2025 ] Aditxt’s (NASDAQ: ADTX) Subsidiary Adimune Highlights Its Approach to Reprogramming the Immune System Through DNA Instructions, Now with 96 Granted and 22 Pending Patents Targeting Autoimmunity Market Estimated at Over $160 Billion by 2030 Newsmakers
[ August 27, 2025 ] Advent Technologies (NASDAQ: ADN) engages Fata Advisory to Support Business Development for Aerospace, Defense, and Commercial Markets Newsmakers
[ August 27, 2025 ] Wellgistics Health (NASDAQ: WGRX) Introduces HubRx AI: Advancing the AI-Powered Prescription Ecosystem Healthcare
[ August 26, 2025 ] Advent (NASDAQ: ADN) Technologies Pursuing Trailblazing Initiatives in Space Aerospace & Defense
[ August 21, 2025 ] Advent Technologies (NASDAQ: ADN) and Global Semiconductor & Wireless Technology Company Sign Agreement for Ion Pair Membrane Development for Gas Sensing Advent Technologies Holdings, Inc. Thu, August 21, 2025 at 5:00 AM PDT 4 min read Aviation

Binary Options: Binary Return Derivatives (ByRDs)

January 16, 2018 admin Investor Education, Options Trading Comments Off

Binary Options: Binary Return Derivatives (ByRDs)

Bill Ryan: Introduction to Binary Options: Binary Return Derivatives (ByRDs)

Advent Technologies (NASDAQ: ADN) Announces Major Milestone in its Strategic Collaboration with Airbus

September 10, 2025 Comments Off on Advent Technologies (NASDAQ: ADN) Announces Major Milestone in its Strategic Collaboration with Airbus
Hoth Therapeutics (NASDAQ: HOTH) Secures Key European Regulatory Milestone with EMA Submission for Phase II Trial of HT-001 in Cancer Patients Suffering from EGFRi-Induced Skin Toxicities

September 10, 2025 Comments Off on Hoth Therapeutics (NASDAQ: HOTH) Secures Key European Regulatory Milestone with EMA Submission for Phase II Trial of HT-001 in Cancer Patients Suffering from EGFRi-Induced Skin Toxicities
Worksport (NASDAQ: WKSP) Posts Fourth Consecutive Monthly Sales Record in July 2025; Gross Margin Reaches 31% Target One Quarter Early

September 10, 2025 Comments Off on Worksport (NASDAQ: WKSP) Posts Fourth Consecutive Monthly Sales Record in July 2025; Gross Margin Reaches 31% Target One Quarter Early
Worksport (NASDAQ: WKSP) Posts Q2 2025 Results: Gross Profit Increases 173%, Revenue Jumps 83%, Margin Expands 870 bps, Operating Loss Improves 15% [QoQ].

September 4, 2025 Comments Off on Worksport (NASDAQ: WKSP) Posts Q2 2025 Results: Gross Profit Increases 173%, Revenue Jumps 83%, Margin Expands 870 bps, Operating Loss Improves 15% [QoQ].
Hoth Therapeutics’ (NASDAQ: HOTH) Cancer Therapeutic HT-KIT Surpasses Preclinical Milestones With Potent Anti-Tumor Activity and GLP-Validated Bioanalytical Results, Exceeding Regulatory Standards

September 4, 2025 Comments Off on Hoth Therapeutics’ (NASDAQ: HOTH) Cancer Therapeutic HT-KIT Surpasses Preclinical Milestones With Potent Anti-Tumor Activity and GLP-Validated Bioanalytical Results, Exceeding Regulatory Standards
Aditxt’s (NASDAQ: ADTX) Subsidiary Adimune Highlights Its Approach to Reprogramming the Immune System Through DNA Instructions, Now with 96 Granted and 22 Pending Patents Targeting Autoimmunity Market Estimated at Over $160 Billion by 2030

August 28, 2025 Comments Off on Aditxt’s (NASDAQ: ADTX) Subsidiary Adimune Highlights Its Approach to Reprogramming the Immune System Through DNA Instructions, Now with 96 Granted and 22 Pending Patents Targeting Autoimmunity Market Estimated at Over $160 Billion by 2030

Next Super Stock: Aditxt (NASDAQ: ADTX) = “Unicorn Farm” of Billion Dollar Healthcare Opportunities & Multiple Shots on Goal for +10X

July 23, 2025 Comments Off on Next Super Stock: Aditxt (NASDAQ: ADTX) = “Unicorn Farm” of Billion Dollar Healthcare Opportunities & Multiple Shots on Goal for +10X
Is this $1.25 stock the Next Billion Dollar Biotech ? NEXT SUPER STOCK Hoth Therapeutics (NASDAQ: HOTH)

June 11, 2025 Comments Off on Is this $1.25 stock the Next Billion Dollar Biotech ? NEXT SUPER STOCK Hoth Therapeutics (NASDAQ: HOTH)
Next Super Stock: Siyata Mobile (NASDAQ: SYTA) $1.50 AI/Mobile Gaming w +10X Upside Potential

May 14, 2025 Comments Off on Next Super Stock: Siyata Mobile (NASDAQ: SYTA) $1.50 AI/Mobile Gaming w +10X Upside Potential
Next Super Stock: Snow Lake Energy (NASDAQ: LITM) “District Scale” Pine Ridge URANIUM Project

May 9, 2025 Comments Off on Next Super Stock: Snow Lake Energy (NASDAQ: LITM) “District Scale” Pine Ridge URANIUM Project

Next Super Stock: Aditxt (NASDAQ: ADTX) = “Unicorn Farm” of Billion Dollar Healthcare Opportunities & Multiple Shots on Goal for +10X

July 23, 2025 Comments Off on Next Super Stock: Aditxt (NASDAQ: ADTX) = “Unicorn Farm” of Billion Dollar Healthcare Opportunities & Multiple Shots on Goal for +10X
Is this $1.25 stock the Next Billion Dollar Biotech ? NEXT SUPER STOCK Hoth Therapeutics (NASDAQ: HOTH)

June 11, 2025 Comments Off on Is this $1.25 stock the Next Billion Dollar Biotech ? NEXT SUPER STOCK Hoth Therapeutics (NASDAQ: HOTH)
Next Super Stock Lottery.com (NASDAQ: LTRY) +10X Upside Potential Building Top Online Brands

May 23, 2025 Comments Off on Next Super Stock Lottery.com (NASDAQ: LTRY) +10X Upside Potential Building Top Online Brands
Next Super Stock: Siyata Mobile (NASDAQ: SYTA) $1.50 AI/Mobile Gaming w +10X Upside Potential

May 14, 2025 Comments Off on Next Super Stock: Siyata Mobile (NASDAQ: SYTA) $1.50 AI/Mobile Gaming w +10X Upside Potential

Copyright 1997-2019 Wall Street Reporter / Octagon Media Corp.